| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
1e-07 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.3 |
3e-07 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
1e-06 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
1e-06 |
| mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-05 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-05 |
| mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
0.25 |
5e-05 |
| mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
6e-05 |